oracea articles ↓

Thanks for the tip from Ben. A clinical trial listed for treating both facial and ocular rosacea with Oracea suggests that Oracea might soon be marketed directly as an ocular rosacea treatment. This phase 2 trial’s purpose is to determine the safety and efficacy of sub-antimicrobial dose doxycycline in the treatment of patients who have both blepharitis and facial rosacea. The trial …

A recent investor presentation from Collagenex shows some interesting insights into how Collagenex are promoting Oracea. Oracea is promoted as safe and effective for long term use. It was reported that the average duration of Oracea therapy is 4 months, compared to an average of 2.5 months for other rosacea prescriptions. 52% of Oracea prescriptions are refills - the presentation suggests that …

There has been a lot of copy written about so-called low dose or anti-inflammatory dose doxycycline. This form of antibiotic therapy is one of the more promising recent therapeutic developments ; it will likely become a widely known and available treatment. This recently published paper shows that a daily dose of 40mg of doxycycline is as effective in reducing the lesions of rosacea as …

A clinical trial, sponsored by CollaGenex, is recruiting patients to see how Oracea compares to doxycycline (100mg once a day) when combined with metrogel 1%. We can see from a Collagenex annual report that COL-101 was the name for Periostat MR, which then became Oracea. Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens Purpose: To compare the safety and efficacy of two treatment …

Collagenex has launched a swish looking consumer and practitioner web site at www.rosaceatoday.com. Collagenex are indirectly using this site to promote their `new’ treatment Oracea as an effective way to treat rosacea. The site is supporting the idea that rosacea is a chronic inflammatory disease.

Many rosacea sufferers are helped by taking systemic antibiotics. This benefit does not lead to the conclusion that rosacea is …